[go: up one dir, main page]

AU2002240013A1 - Chemokines as adjuvants of immune response - Google Patents

Chemokines as adjuvants of immune response

Info

Publication number
AU2002240013A1
AU2002240013A1 AU2002240013A AU2002240013A AU2002240013A1 AU 2002240013 A1 AU2002240013 A1 AU 2002240013A1 AU 2002240013 A AU2002240013 A AU 2002240013A AU 2002240013 A AU2002240013 A AU 2002240013A AU 2002240013 A1 AU2002240013 A1 AU 2002240013A1
Authority
AU
Australia
Prior art keywords
chemokines
adjuvants
immune response
immune
response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002240013A
Inventor
Christophe Caux
Drake Laface
Alain P. Vicari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2002240013A1 publication Critical patent/AU2002240013A1/en
Abandoned legal-status Critical Current

Links

AU2002240013A 2001-01-24 2002-01-22 Chemokines as adjuvants of immune response Abandoned AU2002240013A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/768,917 2001-01-24

Publications (1)

Publication Number Publication Date
AU2002240013A1 true AU2002240013A1 (en) 2002-08-06

Family

ID=

Similar Documents

Publication Publication Date Title
MXPA03006587A (en) Chemokines as adjuvants of immune response.
AU4959199A (en) Chemokines as adjuvants of immune response
AU2002332019A1 (en) Adjuvant compositions
AU2002330053A1 (en) Chemokines as adjuvants of immune response
AU2002254558A1 (en) Novel vaccine
AU2003300921A1 (en) Scriptured outdoor furniture
AU2003291402A1 (en) MIP-1Alpha AND GM-CSF AS ADJUVANTS OF IMMUNE RESPONSE
AU2404601A (en) Novel immune enhancing compositions
AU2002356615A1 (en) Novel utilization of cyclopentabenzofurans
AU2002312487A1 (en) Nucleoside vaccine adjuvants
AU2002233557A1 (en) Immune response potentiation
AU2002240013A1 (en) Chemokines as adjuvants of immune response
AU2002334631A1 (en) Immune response associated proteins
GB2370219B (en) Item of furniture
AU2003239773A1 (en) Preparation of vaccines
AU2002359898A1 (en) Preparation of alpha-diimines
AU2002364161A1 (en) Enhancement of the immune response using cd36-binding domain
AU2002226616A8 (en) Preparation of pure 3-alkoxymethyl cephalosporins.
AU2002251271A1 (en) Stimulation of the immune system
AU2002253048A1 (en) Novel vaccine
AU2002339492A1 (en) Vector used to induce an immune response
AU2002300773A1 (en) Preparation of Dialkylpyridylboranes
AU2002315561A1 (en) Uses of cytokines
AU2002337263A1 (en) Anti-coronavirus vaccine
HK1069982A (en) Vaccine